Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Current treatment strategies include the use of growth factors, CD34(+)-selected stem cell boost, mesenchymal stem cell transfusion, and second allo-HSCT, but these trea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Hematol Oncol
Hlavní autoři: Tang, Cen, Chen, Feng, Kong, Danqing, Ma, Qinfen, Dai, Haiping, Yin, Jia, Li, Zheng, Chen, Jia, Zhu, Xiaming, Mao, Xinliang, Wu, Depei, Tang, Xiaowen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Letter to the Editor
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097332/
https://ncbi.nlm.nih.gov/pubmed/30115080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0649-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky